Corpus Intelligence IC Memo — CLEAR LAKE REG MED CTR 2026-04-26 05:23 UTC
IC Memo — CLEAR LAKE REG MED CTR
Investment Committee Memorandum | TX | 518 beds | Grade C | EBITDA uplift $45.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CLEAR LAKE REG MED CTR

CCN 450617 | HARRIS, TX | 518 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CLEAR LAKE REG MED CTR is a 518-bed suburban community hospital in HARRIS, TX with $614.9M in net patient revenue and a 24.6% operating margin. The hospital serves a payer mix of 19.4% Medicare, 2.5% Medicaid, and 78.1% commercial.

Thesis: Platform Growth. Our ML models identify $45.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 24.6% to 32.0% (+736bps).

Net Revenue HCRIS$614.9M
Current EBITDA COMPUTED$151.6M
Operating Margin COMPUTED24.6%
Occupancy HCRIS74.1%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS10.4%
Distress Probability ML41.1%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
73
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 24.6% places it above the state median. Among 73 size-comparable peers (259-1036 beds), the median margin is 4.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (259-1036), prioritizing same-state peers. 73 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CLEAR LAKE REG MED CTR (Target)TX518$614.9M24.6%
UT MD ANDERSON CANCER CENTERTX721$4.90B-0.8%
THE METHODIST HOSPITALTX966$2.63B5.2%
TEXAS CHILDRENS HOSPITALTX863$2.50B-29.9%
UT SOUTHWESTERN UNIVERSITY HOSTX737$2.28B-4.6%
SCOTT AND WHITE MEMORIAL HOSPITX616$1.85B-10.5%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
COOK CHILDRENS MEDICAL CENTERTX423$1.51B16.5%
MEDICAL CITY DALLASTX819$1.33B49.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $45.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$12.9M+210bp18mo
Cost to Collect4.5%2.5%$12.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$12.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$7.5M+122bp9mo
Clean Claim Rate88.0%96.0%$394K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$12.9M
Cost to Collect
$12.3M
Denial Rate Reduction
$12.2M
A/R Days Reduction
$7.5M
Clean Claim Rate
$394K
Total EBITDA Uplift$45.3M
Current EBITDA$151.6M
+ RCM Uplift+$45.3M
Pro Forma EBITDA$196.8M
Current Margin24.6%
Pro Forma Margin32.0%
WC Released (1x)$23.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$233.2M$1.45B6.23x44.2%
Base (11x exit)10.0x11.0x$233.2M$1.67B7.18x48.3%
Bull Case9.0x11.0x$209.9M$1.90B9.05x55.3%
Bull (12x exit)9.0x12.0x$209.9M$2.13B10.16x59.0%
Bear Case11.0x10.0x$256.5M$1.15B4.48x35.0%
Bear (11x exit)11.0x11.0x$256.5M$1.35B5.26x39.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 73 hospitals with 259-1036 beds
  • Same-state prioritization (n=74)
  • Comp margins: P25=-17.0% / P50=4.5% / P75=13.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.